Use Options For a Chance To Buy HRTX at a 42% Discount

Looking back to 117 days ago, Heron Therapeutics Inc (HRTX) priced a 4,800,000 share secondary stock offering at $24.75 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Monday, the stock is now 6.4% above the offering price..